Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

IM Cannabis (IMCC) Other Operating Expenses (2020 - 2025)

Historic Other Operating Expenses for IM Cannabis (IMCC) over the last 6 years, with Q3 2025 value amounting to $467110.5.

  • IM Cannabis' Other Operating Expenses fell 6358.79% to $467110.5 in Q3 2025 from the same period last year, while for Sep 2025 it was -$916059.8, marking a year-over-year decrease of 11683.05%. This contributed to the annual value of -$3.5 million for FY2024, which is 14285.33% down from last year.
  • As of Q3 2025, IM Cannabis' Other Operating Expenses stood at $467110.5, which was down 6358.79% from -$1.8 million recorded in Q2 2025.
  • In the past 5 years, IM Cannabis' Other Operating Expenses ranged from a high of $5.8 million in Q4 2022 and a low of -$1.8 million during Q2 2025
  • Its 5-year average for Other Operating Expenses is $1.8 million, with a median of $2.0 million in 2023.
  • Its Other Operating Expenses has fluctuated over the past 5 years, first soared by 15077.86% in 2021, then plummeted by 18623.67% in 2024.
  • IM Cannabis' Other Operating Expenses (Quarter) stood at $3.4 million in 2021, then surged by 69.02% to $5.8 million in 2022, then crashed by 65.9% to $2.0 million in 2023, then crashed by 124.38% to -$484629.9 in 2024, then surged by 196.39% to $467110.5 in 2025.
  • Its Other Operating Expenses was $467110.5 in Q3 2025, compared to -$1.8 million in Q2 2025 and $892750.0 in Q1 2025.